Figure 8 Investment Strategies LLC Reduces Holdings in Waters Corporation $WAT

Figure 8 Investment Strategies LLC lowered its position in shares of Waters Corporation (NYSE:WAT) by 26.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,322 shares of the medical instruments supplier’s stock after selling 1,924 shares during the period. Waters comprises about 1.8% of Figure 8 Investment Strategies LLC’s holdings, making the stock its 20th largest position. Figure 8 Investment Strategies LLC’s holdings in Waters were worth $1,858,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. Brighton Jones LLC lifted its stake in Waters by 112.9% in the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after buying an additional 673 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Waters by 15.9% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,318 shares of the medical instruments supplier’s stock valued at $1,602,000 after purchasing an additional 593 shares during the last quarter. Curat Global LLC purchased a new stake in Waters in the 1st quarter valued at $80,000. Procyon Advisors LLC boosted its stake in Waters by 19.6% during the 1st quarter. Procyon Advisors LLC now owns 1,189 shares of the medical instruments supplier’s stock worth $438,000 after purchasing an additional 195 shares during the period. Finally, Fenimore Asset Management Inc grew its position in Waters by 0.4% during the 1st quarter. Fenimore Asset Management Inc now owns 234,488 shares of the medical instruments supplier’s stock worth $86,425,000 after purchasing an additional 1,011 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Stock Performance

Shares of WAT stock opened at $328.95 on Friday. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The stock has a 50 day simple moving average of $296.92 and a 200-day simple moving average of $325.60. The company has a market cap of $19.58 billion, a price-to-earnings ratio of 29.66, a price-to-earnings-growth ratio of 3.00 and a beta of 1.04. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56.

Waters (NYSE:WAT) last posted its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million for the quarter, compared to the consensus estimate of $745.96 million. During the same period in the previous year, the business earned $2.63 earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, equities analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Robert W. Baird reduced their target price on shares of Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a “buy” rating in a research note on Monday, August 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research report on Saturday, September 27th. Wells Fargo & Company dropped their target price on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Finally, Scotiabank reaffirmed a “sector outperform” rating and set a $465.00 price target on shares of Waters in a report on Friday, July 11th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Waters has a consensus rating of “Hold” and a consensus price target of $380.43.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.